- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Inogen Inc(INGN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for INGN
11/13/2026: INGN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Inogen Inc is a medical technology company specializing in portable oxygen concentrators and respiratory health products for homecare settings. The company's core strengths lie in its recognized brand equity and innovative lightweight device engineering, which provide ambulatory freedom to chronic respiratory patients. Its primary investment story centers on an operational turnaround focused on portfolio expansion into adjacent areas like airway clearance and operational streamlining. However, the company faces intense competition from larger medical device conglomerates alongside historical unprofitability and high customer acquisition costs. Inogen suits risk-tolerant growth investors willing to monitor turnaround execution, cost discipline, and new product adoption milestones.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While Inogen operates in an expanding healthcare sub-sector, its historical revenue contraction limits near-term growth appeal. |
| Momentum investor | Weak fit | Momentum fit is conditional on a positive sustained upturn signal, given historical share price volatility. |
| Value investor | Mixed fit | The stock trades at modest price-to-sales multiples, but unprofitability introduces higher fundamental execution risk. |
| Dividend investor | Weak fit | Inogen does not pay dividends, rendering it unsuitable for income-seeking investors. |
| Low-risk investor | Weak fit | High share price volatility and ongoing turnaround execution risks make it unsuitable for risk-averse portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock experiences sharp swings driven by sentiment shifts, quarterly earnings, and turnaround news. |
| Valuation risk | Medium | Low price-to-sales multiples offer some downside buffer, but lack of earnings complicates traditional valuation metrics. |
| Competition risk (large medical device conglomerates) | High | Inogen competes against heavily capitalized rivals with broader global scale and distribution power. |
| Business quality | Medium | Specialized proprietary device technology is offset by historical operating losses and margin pressures. |
| Dividend income | Low / none | The company pays no dividend, offering zero income return. |
| Execution risk | High | Successful turnaround hinges on management's ability to control costs and drive scalable commercial growth. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 147.95M USD | Price to earnings Ratio - | 1Y Target Price 10.75 |
Price to earnings Ratio - | 1Y Target Price 10.75 | ||
Volume (30-day avg) 295.6K shares | Beta 1.49 | 52 Weeks Range 5.04 - 7.67 | Updated Date 11/15/2026 |
52 Weeks Range 5.04 - 7.67 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.21 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Devices
- BUY participation
- 62.5%
- Active BUY / eligible
- 5 / 8
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Downtrend
The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -53.8% | Avg. Invested days 27 | Today’s Advisory WEAK BUY |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Portable Oxygen Concentrators (POC) | Sale and rental of flagship ambulatory devices such as the Inogen One G3, G4, and G5 systems. | This is the core revenue engine where patients pay for lifestyle-oriented mobile oxygen devices. |
| Domestic and International B2B / DTC Channels | Direct sales to consumers and wholesale transactions through home medical equipment providers and international distributors. | Diversified distribution helps reach patients globally, balancing direct marketing costs with wholesale volume. |
| Home Respiratory and Adjacent Products | Stationary concentrators, consumables, and airway clearance products like Simeox. | Newer product categories provide secondary avenues for revenue diversification beyond standard POCs. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 65.91M | Price to Sales(TTM) 0.42 |
Enterprise Value 65.91M | Price to Sales(TTM) 0.42 | ||
Enterprise Value to Revenue 0.19 | Enterprise Value to EBITDA -17.6 | Shares Outstanding 26.00M | Shares Floating 22.59M |
Shares Outstanding 26.00M | Shares Floating 22.59M | ||
Percent Insiders 13.94 | Percent Institutions 81.68 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

